BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21803771)

  • 41. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
    Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK
    Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Direct regulation of HOXA10 by 1,25-(OH)2D3 in human myelomonocytic cells and human endometrial stromal cells.
    Du H; Daftary GS; Lalwani SI; Taylor HS
    Mol Endocrinol; 2005 Sep; 19(9):2222-33. PubMed ID: 15905361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclical chromatin looping and transcription factor association on the regulatory regions of the p21 (CDKN1A) gene in response to 1alpha,25-dihydroxyvitamin D3.
    Saramäki A; Diermeier S; Kellner R; Laitinen H; Vaïsänen S; Carlberg C
    J Biol Chem; 2009 Mar; 284(12):8073-82. PubMed ID: 19122196
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of rat cytochrome P450C24 (CYP24) gene expression. Evidence for functional cooperation of Ras-activated Ets transcription factors with the vitamin D receptor in 1,25-dihydroxyvitamin D(3)-mediated induction.
    Dwivedi PP; Omdahl JL; Kola I; Hume DA; May BK
    J Biol Chem; 2000 Jan; 275(1):47-55. PubMed ID: 10617584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retinoid X receptors stimulate and 9-cis retinoic acid inhibits 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene.
    MacDonald PN; Dowd DR; Nakajima S; Galligan MA; Reeder MC; Haussler CA; Ozato K; Haussler MR
    Mol Cell Biol; 1993 Sep; 13(9):5907-17. PubMed ID: 8395017
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol.
    Chow EC; Magomedova L; Quach HP; Patel R; Durk MR; Fan J; Maeng HJ; Irondi K; Anakk S; Moore DD; Cummins CL; Pang KS
    Gastroenterology; 2014 Apr; 146(4):1048-59. PubMed ID: 24365583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions.
    Herdick M; Steinmeyer A; Carlberg C
    Chem Biol; 2000 Nov; 7(11):885-94. PubMed ID: 11094341
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prostate cancer cell type-specific involvement of the VDR and RXR in regulation of the human PTHrP gene via a negative VDRE.
    Sepulveda VA; Weigel NL; Falzon M
    Steroids; 2006 Feb; 71(2):102-15. PubMed ID: 16243370
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characteristics of vitamin D3 receptor (VDR) binding to the vitamin D response element (VDRE) in rat bone sialoprotein gene promoter.
    Li JJ; Kim RH; Zhang Q; Ogata Y; Sodek J
    Eur J Oral Sci; 1998 Jan; 106 Suppl 1():408-17. PubMed ID: 9541257
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of a vitamin D3-response element that overlaps a unique inverted TATA box in the rat bone sialoprotein gene.
    Kim RH; Li JJ; Ogata Y; Yamauchi M; Freedman LP; Sodek J
    Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):219-26. PubMed ID: 8761475
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclical regulation of the insulin-like growth factor binding protein 3 gene in response to 1alpha,25-dihydroxyvitamin D3.
    Malinen M; Ryynänen J; Heinäniemi M; Väisänen S; Carlberg C
    Nucleic Acids Res; 2011 Jan; 39(2):502-12. PubMed ID: 20855290
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterizing early events associated with the activation of target genes by 1,25-dihydroxyvitamin D3 in mouse kidney and intestine in vivo.
    Meyer MB; Zella LA; Nerenz RD; Pike JW
    J Biol Chem; 2007 Aug; 282(31):22344-52. PubMed ID: 17556365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.
    Dunlop TW; Väisänen S; Frank C; Molnár F; Sinkkonen L; Carlberg C
    J Mol Biol; 2005 Jun; 349(2):248-60. PubMed ID: 15890193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The vitamin D response element in the distal osteocalcin promoter contributes to chromatin organization of the proximal regulatory domain.
    Gutierrez S; Liu J; Javed A; Montecino M; Stein GS; Lian JB; Stein JL
    J Biol Chem; 2004 Oct; 279(42):43581-8. PubMed ID: 15299011
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vitamin D-dependent rickets type II: regulation of human osteocalcin gene expression in cells with defective vitamin D receptors by 1,25-dihydroxyvitamin D-3, retinoic acid, and triiodothyronine.
    Takeda E; Miyamoto K; Kubota M; Minami H; Yokota I; Saijo T; Naito E; Ito M; Kuroda Y
    Biochim Biophys Acta; 1994 Nov; 1227(3):195-9. PubMed ID: 7986828
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 9-cis retinoic acid accelerates calcitriol-induced osteocalcin production and promotes degradation of both vitamin D receptor and retinoid X receptor in human osteoblastic cells.
    Jääskeläinen T; Ryhänen S; Mäenpää PH
    J Cell Biochem; 2003 Aug; 89(6):1164-76. PubMed ID: 12898515
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Salt concentration determines 1,25-dihydroxyvitamin D3 dependency of vitamin D receptor-retinoid X receptor--vitamin D-responsive element complex formation.
    Kimmel-Jehan C; Jehan F; DeLuca HF
    Arch Biochem Biophys; 1997 May; 341(1):75-80. PubMed ID: 9143355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs.
    Liu Y; Shen Q; Malloy PJ; Soliman E; Peng X; Kim S; Pike JW; Feldman D; Christakos S
    J Bone Miner Res; 2005 Sep; 20(9):1680-91. PubMed ID: 16059639
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resistance of HBL100 human breast epithelial cells to vitamin D action.
    Agadir A; Lazzaro G; Zheng Y; Zhang XK; Mehta R
    Carcinogenesis; 1999 Apr; 20(4):577-82. PubMed ID: 10223184
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy.
    Sanchez-Niño MD; Bozic M; Córdoba-Lanús E; Valcheva P; Gracia O; Ibarz M; Fernandez E; Navarro-Gonzalez JF; Ortiz A; Valdivielso JM
    Am J Physiol Renal Physiol; 2012 Mar; 302(6):F647-57. PubMed ID: 22169009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.